Dr. Labros Meimetis

Biography

Labros Meimetis is a Research Assistant Professor in the Department of Radiology at the University of Wisconsin-Madison. Born and raised in Vancouver, Canada, he received his B.S. in Chemistry from Simon Fraser University and his Ph.D. in Chemistry from the University of British Columbia. His research focuses on total synthesis and structure-activity relationship studies of pharmacologically active compounds derived from marine and terrestrial sources, with a particular emphasis on targeting the PI3K pathway and androgen receptor cathepsin K. He completed postdoctoral research at Harvard Medical School, where he developed a series of fluorogenic imaging probes and bimodal 89Zr-based PET tracers for cancer imaging. He has also worked in the biotechnology sector as a Senior Scientist, focusing on preclinical discovery programs to develop new linker-payloads for antibody-drug conjugates aimed at treating cancer. Dr. Meimetis has led Chronus Pharmaceuticals as Chief Executive Officer, advancing PET tracers for infectious diseases. Prior to his current role, he was a Research Assistant Professor and later an Assistant Professor in the Department of Radiology at Stony Brook University, and he is dedicated to developing therapies for difficult-to-treat cancers, with special emphasis on addressing tumor heterogeneity and immunosuppression in late-stage cancers. He has achieved significant milestones by inventing new immunostimulatory radiopharmaceuticals and antibody-drug conjugates.

Research Interests